II.2.3) Place of performance
II.2.4) Description of the procurement
NHS England (London) is seeking to identify professional, capable Providers to deliver the Abdominal Aortic Aneurysm Screening Programme (AAASP) across South London which also includes East Surrey and parts of Surrey Downs CCGs. One contract will be awarded (one tender Lot).
The contract will be part block and part activity based. The block will ensure all costs are covered to support service delivery to current performance standards (75 % uptake). A tariff payment per screen will be offered for all men screened, who are part of the eligible cohort for that year, where uptake performance exceeds 75 %. The maximum value of the block element is based on 75 % uptake including self-referrals and surveillance (based on figure form 2018/19): Total — 755 000 GBP per year for years 1-3 and 695 000 GBP for year 4 (ex VAT).
This associated tariff payment will be 60 GBP per screen (up to a maximum payment of 227 000 GBP per year).
This will cover;
— initial screens,
— surveillance screens,
— non-visualised screens below the acceptable level set by the National AAASP (per year).
The tender submission deadline is 12:00 (noon) on 18.12.2018.
The contract start date is 1.9.2019. The contract period will be 3 years (36 months) followed by an optional extension of up to 1 year (12 months). Therefore the maximum contract duration, including available extensions, is 4 years (48 months). Award will be made against The NHS Standard Contract (currently 2017-2019, we expect these terms to be updated during this procurement so it may be necessary to contract against the revised version. Should this be the case then we will publish the revised version via the portal in advance of any award).
The service provider will:
— invite eligible men to the AAASP using standard information provided by Public Health England (PHE),
— provide clear, high quality information that is accessible to all,
— carry out high quality abdominal ultrasound on those men attending for initial or follow-up screening according to national protocol,
— minimise any adverse effects of screening, including anxiety and unnecessary investigations,
— identify Abdominal Aortic Aneurysm's accurately,
— enable men to make an informed choice about the management of their Abdominal Aortic Aneurysm,
— ensure appropriate and effective management of cardiovascular risk factors identified through screening,
— ensure referral to accredited vascular services for high quality diagnostic and treatment services,
— promote audit and research and learn from the results.
The Services will be subject to an annual PHE Quality Assurance (QA) review and effectiveness of treatment will be monitored via annual reports of a National Vascular Review.
II.2.5) Award criteria
Quality criterion: Quality
/ Weighting: 90
II.2.6) Estimated value
Value excluding VAT: 3 868 000.00 GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
This contract is subject to renewal: Yes
Description of renewals:
The contract period will be 3 years (36 months) followed by an optional extension of up to 1 year (12 months). Therefore the maximum contract duration, including available extensions, is 4 years (48 months).
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
II.2.11) Information about options
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: